Smartlab Europe

News

Lonza and Junshi Biosciences Collaborate to Accelerate the Development and Manufacturing of Biologics

"The signing of this collaboration indicates that the relationship between the two parties has been taken to a new level. As a major milestone for Lonza's biopharmaceutical facility in Guangzhou, the collaboration also demonstrates Lonza's vision to provide high-quality...

Smart excipient improves powder flow for sachet-based products

Sachets are a popular pharmaceutical and nutraceutical packaging format for consumers and manufacturers alike. To ensure accurate dosage and administration, the powders used in these delivery systems require excellent flowability. BENEO’s filler-binder galenIQ™ 721 meets this demand and helps...

SGD Pharma continues customer-led innovation with range extension for Sterinity Ready-to-Use molded glass vials

Worldwide glass primary packaging supplier SGD Pharma announces the continued expansion of its Ready-to-Use (RTU) Sterinity molded glass vial platform with the introduction of amber glass 50ml volume option in Tray, now available ex-stock. The addition of 50ml amber molded...

InSilicoTrials wins 3 Horizon 2020 projects to support innovation

Italian startup InSilicoTrials submitted 9 Horizon 2020 projects and won 3, thus significantly exceeding the average success rate that is around 5%. A great achievement for a small but rapidly expanding company that found its own positioning in the...

Bora Pharmaceuticals Adds Roller Compaction Capabilities

Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility is a leader in the manufacture of complex...

Olympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Busines

Olympus Corporation announced  the opening of a new facility in Westborough,MA, to serve as the global headquarters for its Therapeutic Solutions Division (TSD) and its medical business in the United States. Olympus has identified TSD as a strategic focus for...

Claritas to expand Covid-19 trial to include sepsis treatment

Claritas Pharmaceuticals is set to expand its development programme for R-107 to include the treatment of Covid-19 related sepsis, which is the leading cause of death in infected patients. The body has a dysregulated immune response to SARS-CoV-2 in Covid-19...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »